TIRZEPATIDE
For professional use only
Certified Research
Product information
Tirzepatide is a GIP and GLP-1 receptor agonist. In approved formulations, it is used under medical prescription for the treatment of type 2 diabetes and, in specific presentations, for chronic weight management.
It enhances glucose-dependent insulin secretion, decreases glucagon secretion, delays gastric emptying, and increases satiety.
Available doses and presentations
5mg
Starter
10mg
Intermediate
60mg
Advanced
120mg
Maximum
Purity
99%
Form
Lyophilized
Application
Subcutaneous
Content
1 Vial